OTC: HNOI
HNO International, Inc.CIK 0001342916 · SIC 1000 · Metal Mining
Micro
Revenue $66K
Assets $1M
as of Aug 16, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (WOLF 10-K) is open in full — no account needed.
424B3
Filed Jul 28, 2026
Summary not yet generated.
S-1
Filed Jul 21, 2026
Summary not yet generated.
Partner
Trade HNOI commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
10-Q
Filed Jul 7, 2026
· Period ending Apr 30, 2026
Summary not yet generated.
8-K
Filed May 8, 2026
· Period ending May 5, 2026
Summary not yet generated.
8-K
Filed May 1, 2026
· Period ending Apr 27, 2026
Summary not yet generated.
8-K
Filed Apr 17, 2026
· Period ending Apr 7, 2026
Summary not yet generated.
8-K
Filed Apr 16, 2026
· Period ending Apr 13, 2026
Summary not yet generated.
Latest financial statements
From 10-Q filed Jul 7, 2026 (period ending Apr 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statements of Operations (Unaudited)
| Description | Three months ended April 30, 2026 | Three months ended April 30, 2025 | Six months ended April 30, 2026 | Six months ended April 30, 2025 |
|---|---|---|---|---|
| Revenue | 33,821 | 43,708 | 33,821 | 43,708 |
| Cost of goods sold | — | — | — | — |
| Gross Profit | 33,821 | 43,708 | 33,821 | 43,708 |
| Operating expenses | ||||
| Advertising and marketing | 1,706 | 14,810 | 2,559 | 20,160 |
| General and administrative expenses | 165,081 | 314,323 | 286,570 | 5,708,985 |
| Share commitment expenses | 55,000 | — | 55,000 | — |
| Depreciation | 63,436 | 57,539 | 128,653 | 111,988 |
| Total Operating Expenses | 285,223 | 386,672 | 472,782 | 5,841,133 |
| Net loss from Operations | (251,306) | (342,964) | (438,961) | (5,797,425) |
| Other Income (Expenses) | ||||
| Interest income | 5 | 5 | 6 | 5 |
| Interest expense | (39,633) | (6,932) | (46,565) | (13,864) |
| Gain/(Loss) on fair value of convertible note | (100,581) | (14,985) | (88,160) | (14,985) |
| Gain/(Loss) on derivative | (9,214) | — | (9,214) | — |
| Loss on write-off of intangible asset | — | (105,190) | — | (105,190) |
| Total Other (Expenses) | (149,423) | (127,102) | (143,933) | (134,034) |
| Net Loss | (400,825) | (470,066) | (582,894) | (5,931,459) |
| PER SHARE AMOUNTS | ||||
| Basic and diluted net loss per share | — | (0.01) | (0.01) | (0.03) |
| Weighted average number of common shares outstanding basic and diluted | 101,838,843 | 78,534,293 | 101,594,846 | 211,773,082 |
| The accompanying notes are an integral part of these condensed unaudited financial statements. | ||||
Condensed Balance Sheets
| Description | April 30, 2026 Unaudited | October 31, 2025 Audited |
|---|---|---|
| Current Assets | ||
| Cash | 145,670 | 9,525 |
| Accounts receivable | — | 332,669 |
| Other receivable | — | 1,000 |
| Total Current Assets | 145,670 | 343,194 |
| Non-Current Assets | ||
| Property and equipment, net | 1,207,704 | 1,323,189 |
| Right-of-use asset | 35,161 | 64,637 |
| Total Non-Current Assets | 1,242,865 | 1,387,826 |
| TOTAL ASSETS | 1,388,535 | 1,731,020 |
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
| LIABILITIES | ||
| Current Liabilities | ||
| Accounts payable | 375,213 | 715,236 |
| Accrued payroll | (18) | (18) |
| Accrued interest payable | 69,982 | 56,345 |
| Lease liability | 36,045 | 60,953 |
| Advances, related party | 1,288,385 | 1,088,385 |
| Convertible note payable, at fair value | 12,531 | 59,867 |
| Notes payable, related party | 785,000 | 785,000 |
| Derivative liability | 192,500 | — |
| Total Current Liabilities | 2,759,638 | 2,765,768 |
| Non-Current Liability | ||
| Lease liability | — | 5,202 |
| Long term notes payable, related party | 590,000 | 590,000 |
| Total Non-Current Liability | 590,000 | 595,202 |
| Total Liabilities | 3,349,638 | 3,360,970 |
| STOCKHOLDERS’ DEFICIT | ||
| Preferred stock, par value $0.001 per share; 15,000,000 shares authorized | ||
| Series A, par value $0.001 per share; 10,000,000 shares authorized; 5,000,000 and 5,000,000 shares issued and outstanding as of April 30, 2026 and October 31, 2025, respectively | 5,000 | 5,000 |
| Series B, par value $0.001 per share; 500,000 shares authorized; 360,000 and 360,000 shares issued and outstanding as of April 30, 2026 and October 31, 2025, respectively | 360 | 360 |
| Common stock, par value $0.001 per share; 985,000,000 shares authorized; 101,821,989 and 100,795,491 shares issued and outstanding as of April 30, 2026 and October 31, 2025, respectively | 101,822 | 100,795 |
| Common stock payable | 85,250 | 25,250 |
| Common stock subscription receivable | (13,750) | (13,750) |
| Additional paid-in capital | 50,493,299 | 50,302,585 |
| Accumulated deficit | (52,633,084) | (52,050,190) |
| Total Stockholders’ Deficit | (1,961,103) | (1,629,950) |
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | 1,388,535 | 1,731,020 |
| The accompanying notes are an integral part of these condensed unaudited financial statements. | ||
Condensed Statements of Cash Flows (Unaudited)
| Description | Six months ended April 30, 2026 | Six months ended April 30, 2025 |
|---|---|---|
| Cash Flow from Operating Activities | ||
| Net loss | (582,894) | (5,931,459) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation | 128,653 | 111,988 |
| Non cash interest expenses | 12,531 | — |
| Legal services provided in exchange for convertible note | — | 45,000 |
| Loss on write-off of intangible asset | — | 105,190 |
| (Gain)/Loss on fair value of convertible note | 88,160 | 14,985 |
| (Gain)/Loss on derivative liability | 9,214 | |
| Share based compensation | — | 5,092,557 |
| Changes in operating assets and liabilities: | ||
| (Increase)/Decrease in accounts receivable | 332,669 | (8,450) |
| Decrease in other receivable | 1,000 | — |
| (Decrease) in accounts payable | (340,023) | (106,116) |
| Increase/(Decrease) in accrued payroll | — | (8,881) |
| Increase in accrued interest payable | 13,637 | 13,864 |
| Operating lease ROU assets and lease liabilities, net | (634) | 125 |
| Net Cash Used in Operating Activities | (337,687) | (671,197) |
| Cash Flows from Financing Activities | ||
| Proceeds from related party advances | 230,000 | 509,000 |
| Repayment of related party advances | (30,000) | (150,000) |
| Proceeds from sale of common stock subscription payable | 60,000 | — |
| Proceeds from sale of common stock | 62,500 | 542,500 |
| Proceeds from issuance of convertible notes payable | 314,500 | — |
| Repayment of convertible notes payable | (150,000) | — |
| Net Cash Provided by Financing Activities | 487,000 | 901,500 |
| Cash Flows from Investing Activities | ||
| Purchase of property and equipment | (13,168) | (177,944) |
| Net Cash Used in Investing Activities | (13,168) | (177,944) |
| Net increase (decrease) in cash | 136,145 | 52,359 |
| Cash at beginning of period | 9,525 | 20,255 |
| Cash at end of period | 145,670 | 72,614 |
| Supplemental Disclosure for Cash Paid: | ||
| Lease liability paid during the period | 31,089 | — |
| Income taxes paid during the period | — | — |
| Interest paid during the period | 897 | — |
| Supplemental Disclosure for Non-Cash Investing and Financing Activities: | ||
| Property and equipment acquired through accounts payable | 348,845 | 398,845 |
| Common stock cancellation per share exchange agreement | — | (360,000) |
| Series B preferred stock issuance per exchange agreement | — | 360,000 |
| Shares issued for redemption of convertible notes payable | 47,446 | — |
| Convertible note issued in exchange for legal services, recorded at fair value | — | 59,985 |
| Derivative liability balance | 192,500 | — |
| The accompanying notes are an integral part of these condensed unaudited financial statements. | ||
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗